Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Buprenorphine Transdermal System vs Oxycodone in Osteoarthritis Pain
NCT00312221Phase 3Terminated
- Sponsor
- Purdue Pharma
- Start
- Apr 2004
- Primary completion
- Jul 2005
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of v1003 in osteoarthritis (OA), sponsored by Purdue Pharma. Started Apr 2004; status: terminated.
02
Drugs
v1003
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00312221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312221.